{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:27:17Z","timestamp":1781220437557,"version":"3.54.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"51","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","award":["#227041-2008"],"award-info":[{"award-number":["#227041-2008"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["#MOP-89833"],"award-info":[{"award-number":["#MOP-89833"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.vaccine.2015.10.123","type":"journal-article","created":{"date-parts":[[2015,11,6]],"date-time":"2015-11-06T12:36:03Z","timestamp":1446813363000},"page":"7245-7253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine"],"prefix":"10.1016","volume":"33","author":[{"given":"Damien","family":"Carignan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Th\u00e9rien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7719-2811","authenticated-orcid":false,"given":"Gervais","family":"Rioux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Paquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-\u00c8ve Lalibert\u00e9","family":"Gagn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maril\u00e8ne","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-1638","authenticated-orcid":false,"given":"Denis","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.123_bib0190","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/jinf.2000.0652","article-title":"Influenza virus: a master of metamorphosis","volume":"40","author":"de Jong","year":"2000","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2334-13-81","article-title":"Vaccination strategies for future influenza pandemics: a severity-based cost effectiveness analysis","volume":"13","author":"Kelso","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0200","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1756-0500-6-227","article-title":"Monitoring the antigenic evolution of human influenza A viruses to understand how and when viruses escape from existing immunity","volume":"6","author":"Liao","year":"2013","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0205","first-page":"119","article-title":"Pandemic preparedness and the Influenza Risk Assessment Tool (IRAT)","volume":"385","author":"Cox","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1473-3099(11)70295-X","article-title":"Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis","volume":"12","author":"Osterholm","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0215","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1146\/annurev-med-120611-145115","article-title":"Toward a universal influenza virus vaccine: prospects and challenges","volume":"64","author":"Pica","year":"2013","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0220","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11262-010-0547-7","article-title":"A viruses: why focusing on M2e-based universal vaccines","volume":"42","author":"Ebrahimi","year":"2011","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0230","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.micinf.2004.10.006","article-title":"Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine design","volume":"7","author":"Liu","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0235","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1006\/viro.1995.1498","article-title":"Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly","volume":"212","author":"Hughey","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0240","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection","volume":"254","author":"Mozdzanowska","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0245","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0250","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.antiviral.2008.06.002","article-title":"Therapeutic potential of a fully human monoclonal antibody against influenza A virus M2 protein","volume":"80","author":"Wang","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0255","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0260","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1016\/j.vaccine.2009.07.007","article-title":"M2e-based universal influenza A vaccine","volume":"27","author":"Fiers","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0265","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.virol.2007.01.011","article-title":"Immunogenicity of papaya mosaic virus-like particles fused to a hepatitis C virus epitope: evidence for the critical function of multimerization","volume":"363","author":"Denis","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0270","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1128\/JVI.01811-07","article-title":"Novel plant virus-based vaccine induces protective cytotoxic T-lymphocyte-mediated antiviral immunity through dendritic cell maturation","volume":"82","author":"Lacasse","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0275","doi-asserted-by":"crossref","first-page":"e21522","DOI":"10.1371\/journal.pone.0021522","article-title":"Improvement of the trivalent inactivated flu vaccine using PapMV nanoparticles","volume":"6","author":"Savard","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0280","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0285","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1477-3155-11-10","article-title":"Engineering of papaya mosaic virus (PapMV) nanoparticles with a CTL epitope derived from influenza NP","volume":"11","author":"Babin","year":"2013","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0290","doi-asserted-by":"crossref","first-page":"e31925","DOI":"10.1371\/journal.pone.0031925","article-title":"Engineering of papaya mosaic virus (PapMV) nanoparticles through fusion of the HA11 peptide to several putative surface-exposed sites","volume":"7","author":"Rioux","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0295","first-page":"1","article-title":"Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge","author":"Mathieu","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0300","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1477-3155-12-19","article-title":"PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine","volume":"12","author":"Rioux","year":"2014","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0305","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1165\/ajrcmb.10.6.8003337","article-title":"Depletion of murine CD4+ T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia","volume":"10","author":"Gavett","year":"1994","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0310","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.142.3.954","article-title":"Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis","volume":"142","author":"Israelski","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0315","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/eji.201343738","article-title":"A CD40\/CD40L feedback loop drives the breakdown of CD8(+) T-cell tolerance following depletion of suppressive CD4(+) T cells","volume":"44","author":"Muth","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0320","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nmeth.2935","article-title":"Olfactory exposure to males, including men, causes stress and related analgesia in rodents","volume":"11","author":"Sorge","year":"2014","journal-title":"Nat Methods"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0325","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.imlet.2004.03.003","article-title":"Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge","volume":"93","author":"Liu","year":"2004","journal-title":"Immunol Lett"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0330","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.intimp.2004.12.005","article-title":"The epitope recognized by a monoclonal antibody in influenza A virus M2 protein is immunogenic and confers immune protection","volume":"5","author":"Zou","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0335","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.1302030","article-title":"Nanoparticle adjuvant sensing by TLR7 enhances CD8+ T cell-mediated protection from Listeria monocytogenes infection","volume":"192","author":"Lebel","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0340","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/eji.201041225","article-title":"Universal vaccine against influenza virus linking TLR signaling to anti-viral protection","volume":"42","author":"Schmitz","year":"2012","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0345","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"Huber","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0350","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1750-2659.2011.00331.x","article-title":"Influenza research database: an integrated bioinformatics resource for influenza research and surveillance","volume":"6","author":"Squires","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0355","first-page":"121","article-title":"Predicting flexible length linear B-cell epitopes","volume":"7","author":"El-Manzalawy","year":"2008","journal-title":"Comput Syst Bioinform Conf"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0360","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0365","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","volume":"22","author":"Kim","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2015.10.123_bib0370","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15015790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T19:40:33Z","timestamp":1692128433000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15015790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":37,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0264410X15015790"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.123","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}